Close

Oncosec Medical (ONCS) Announces Positive Interim Data from ImmunoPulse IL-12 + KEYTRUDA Trial in Metastatic Melanoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. META
5. SPOT
6. BA
7. V
8. IBM
9. KMB
10. HCP


Go back to Oncosec Medical (ONCS) Announces Positive Interim Data from ImmunoPulse IL-12 + KEYTRUDA Trial in Metastatic Melanoma
Merck & Co. (NYSE: MRK) Delayed: 127.00 +0.12 (0.09%)
Previous Close $126.88    52 Week High $65.46 
Open $126.82    52 Week Low $47.97 
Day High $127.59    P/E 86.39 
Day Low $125.35    EPS $1.47 
Volume 7,127,871       

OncoSec Medical Incorporated (NASDAQ: ONCS) Delayed: 0.28 --0 (-0%)
Previous Close $0.28    52 Week High $3.49 
Open $0.28    52 Week Low $1.36 
Day High $0.28    P/E N/A 
Day Low $0.28    EPS $-0.04 
Volume 34